MAP1LC3B and skin pigmentation disorder: In essence, TLNVs mitigate the expression of pro-inflammatory cytokines TNF-α and IL-1β, ameliorate the inflammatory milieu, and foster melanin degradation through an autophagy pathway governed by LC3B and P62, underscoring its prospective utility in ameliorating skin pigmentation disorders.